BioSpace News Archive

TB Alliance welcomes Kim Schwartz and Rasha Hibri to its Board of Directors. Their expertise will help guide the organization as it continues to advance its research and product delivery agenda.

Therapeutic Solutions International announced positive data and filing of a patent covering the use of CampbellCell for treatment of Bipolar Disorder by the Company’s suicide prevention based spin-off Campbell Neurosciences.

Elevation Spine, Inc., the leading innovator of integrated-fixation spinal technologies, today announced the completion of its Series B Preferred Stock financing, totaling $11 million.

Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company developing a potent, highly selective, oral KIT inhibitor for the treatment of severe inflammatory diseases, today announced the closing of its initial public offering of 12,535,000 shares of its common stock, including the full exercise of the underwriters’ option to purchase up to 1,635,000 additional shares of common stock, at a public offering price of $17.00 per share.

Bebird, the current leader in visual ear cleaning device sales, is pleased to announce the historic deregulation of the hearing aid industry.

InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development and manufacturing of rare cannabinoids, will report financial results on Friday, September 23, 2022 for the fiscal year ended June 30, 2022.

Curis, Inc. announced that the 2nd Annual VISTA Symposium will take place virtually on September 23, 9:00am-1:00pm ET.